Tamar Robotics, an Israeli developer of neurosurgical robotic technology solutions of the Tamar NIV group, announced Tuesday that it has developed and deployed a novel protective patient hood that the company says prevents the spread of COVID-19 and protects hospital workers who apply non-invasive ventilation (NIV) therapy to patients with the virus.
The product, called NIV Greenhouse, enables the use of non-invasive ventilation such as CPAP and BiPAP devices in COVID-19 treatment. These machines were previously deemed too risky for medical staff due to the potential for the spread of contagious disease from the patient’s breath.
The product is a personal patient hood connected to a standard clean room filter. The product is easy to install and operate, the company says.
The NIV Greenhouse combines air filtration around the patient’s head at levels that until now were only available in clean rooms used in the high-tech industry, together with a personal patient hood that shields the medical staff from the patient’s head.
Use of the product conforms with the Israel Ministry of Health’s regulation that respiratory support of COVID-19 patients should be provided in a protected environment in order to ensure the safety of the medical staff.
“The rapid spread of the COVID-19 virus has necessitated that we dedicate entire wards to these patients in order to prevent the spread of this highly contagious disease, and the swift deployment of Tamar’s NIV Greenhouse hood represents a promising tool in protecting our medical teams and our patients,” said Dr. Ori Segol, head of the coronavirus center ward at the Carmel Medical Center in Haifa.
The NIV Greenhouse is already contributing to the treatment of COVID -19 patients on the front lines, Tamar Robotics says. Initial units have already been installed and are in use at Carmel Medical Center, Ein Kerem Hospital in Jerusalem’s Hadassah Medical Center.
Additional hospitals in Israel and countries around the world have expressed interest in incorporating the product within their COVID-19 wards, the company says.
“Our system, which is the first of its kind, enables non-invasive ventilation treatment to COVID-19 patients in a safe manner to both the patient and medical staff,” said Hadas Ziso, CTO and co-founder of Tamar NIV. “The unique design of our NIV Greenhouse hood allows patients to see and speak to the medical team while simultaneously enhancing breathing performance.”
Tamar NIV is part of the Tamar group of companies, which includes Tamar Robotics, a company developing a cutting-edge robotic system to offer highly accurate, minimally invasive brain surgery.
The rapid development and initial installation of the NIV Greenhouse was a result of the call to action of the Tamar R&D and engineering teams with the encouragement of Tamar’s investors Professor Moshe Shoham, Mivtach Shamir and the Technion-Israel Institute of Technology.
“Our mission at Tamar is to provide medical teams with the best technological advances, enabling treatment with maximum protection,” said Noam Hassidov, CEO of Tamar NIV. “The deployment of our NIV Greenhouse™ hood is the first immediate project from Tamar, with next generations coming to support the new and urgent challenges facing first responders around the world. We want to thank our investors and, in turn, express our gratitude to the medical teams around the world for their tireless work and dedication.”
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
Editors’ & Readers’ Choice: 10 Favorite NoCamels Articles
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
Facebook comments